158 related articles for article (PubMed ID: 6190882)
1. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
Zimakoff J; Høiby N; Rosendal K; Guilbert JP
J Hosp Infect; 1983 Mar; 4(1):31-40. PubMed ID: 6190882
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre.
Zembrzuska-Sadkowska E; Sneum M; Ojeniyi B; Heiden L; Høiby N
J Hosp Infect; 1995 Jan; 29(1):1-7. PubMed ID: 7738336
[TBL] [Abstract][Full Text] [Related]
3. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
[TBL] [Abstract][Full Text] [Related]
4. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.
Speert DP; Campbell ME
J Hosp Infect; 1987 Jan; 9(1):11-21. PubMed ID: 2880893
[TBL] [Abstract][Full Text] [Related]
5. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
[TBL] [Abstract][Full Text] [Related]
6. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
[TBL] [Abstract][Full Text] [Related]
7. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
8. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period.
Bosshammer J; Fiedler B; Gudowius P; von der Hardt H; Römling U; Tümmler B
J Hosp Infect; 1995 Dec; 31(4):261-74. PubMed ID: 8926376
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.
Ojeniyi B; Frederiksen B; Hoiby N
Pediatr Pulmonol; 2000 Mar; 29(3):177-81. PubMed ID: 10686037
[TBL] [Abstract][Full Text] [Related]
10. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P
J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636
[TBL] [Abstract][Full Text] [Related]
11. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
[TBL] [Abstract][Full Text] [Related]
13. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
Festini F; Taccetti G; Galici V; Neri S; Bisogni S; Ciofi D; Braggion C
Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic.
DA Silva Filho LVF; Levi JE; Bento CNO; Rodrigues JC; DA Silva Ramos SRT
J Med Microbiol; 2001 Mar; 50(3):261-267. PubMed ID: 11232773
[TBL] [Abstract][Full Text] [Related]
15. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
[TBL] [Abstract][Full Text] [Related]
16. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
Jones AM; Govan JR; Doherty CJ; Dodd ME; Isalska BJ; Stanbridge TN; Webb AK
Lancet; 2001 Aug; 358(9281):557-8. PubMed ID: 11520529
[TBL] [Abstract][Full Text] [Related]
17. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
Pedersen SS; Jensen T; Pressler T; Høiby N; Rosendal K
Acta Paediatr Scand; 1986 Sep; 75(5):840-5. PubMed ID: 3105236
[TBL] [Abstract][Full Text] [Related]
18. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
Armstrong D; Bell S; Robinson M; Bye P; Rose B; Harbour C; Lee C; Service H; Nissen M; Syrmis M; Wainwright C
J Clin Microbiol; 2003 May; 41(5):2266-7. PubMed ID: 12734299
[No Abstract] [Full Text] [Related]
19. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
